WCN26-2362 POLYPHARMACY AMONG PEOPLE LIVING WITH CHRONIC KIDNEY DISEASE: FINDINGS FROM THE CANADIAN PRIMARY CARE SENTINEL SURVEILLANCE NETWORK

Read full text Summarise with VIRAT
Authors: Paul Everett Ronksley, Himasara Pathiraja, Dee A. Mangin, Alex Singer, Charlotte Jensen, Leanne Kosowan, Heidi Cheung, Kerry McBrien, Tyler S. Williamson, Allan K. Grill, Scott Brimble, Navdeep Tangri
+3 more Dorothea Nitsch, Neil Drummond, Aminu Bello
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

People living with chronic kidney disease (CKD) frequently manage a number of comorbid conditions and require multiple medications (i.e., polypharmacy). Polypharmacy is a growing concern globally and is associated with adverse health outcomes including falls/fractures and increased acute care utilization. Unfortunately, there is limited research exploring its burden and consequences in CKD. In this study, we used data from the Canadian Primary Care Sentinel Surveillance Network to determine the burden of polypharmacy in people living with CKD managed by primary care providers and how this varies by CKD stage and patient demographics.

Fields of Study & Subjects

Pharmaceutical Practices and Patient Outcomes Chronic Disease Management Strategies Pharmacy and Medical Practices

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104702–104702
Publication date
25 March 2026
Language
EN